Multi-center, Single Arm, Observational Study to Evaluate the Safety of Dapagliflozin in Type 2 Diabetes Mellitus Patients in China
Clinical trial NCT03156985 · COMPLETED
Trial details
- NCT number
- NCT03156985
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-08-16
- Primary completion
- 2021-01-27
- Enrollment
- 3000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.